Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ROPINIROLE HYDROCHLORIDE
- A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease
- DIalysis Symptom COntrol-Restless Legs Syndrome Trial
- Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD
- Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
- Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
- A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
- Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions
- Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions
- Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets
- A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease
- A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
- Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition
- Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition
- A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease
- A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease
- Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects
- Cognitive Remediation for Cocaine Dependence
- A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda
- REQUIP RLS Post Marketing Surveillance
- A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa
- Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists
- Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemo
- Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily
- The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions
- Ropinirole 0.25 mg Tablets Under Fasting Conditions
- Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease
- A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions
- A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions
- Neuroma Injections to Treat Restless Legs Syndrome - RCT
- Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164
- Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type
- An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
- An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease
- Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
- REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
- Impact of Switching to Continuous Release Dopamine Agonists
- Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
- A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
- Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
- Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
- 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
- Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
- A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
- Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
- The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
- Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
- SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
- A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
- Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
- A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
- Long-term Study Of Ropinirole In Restless Legs Syndrome
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
- Ropinirole in the Treatment of Bipolar Depression
- Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
- Pramipexole Conversion to Ropinirole Controlled Release (CR)
- Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
- Fibromyalgia Study In Adults
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
- A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease
- A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease
- A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
- Trial of Ropinirole in Motor Recovery After Stroke
- Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
- Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
- Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients
- Ropinirole Tablets In Young Patients With Restless Legs Syndrome
- ACP-103 to Treat Parkinson's Disease
- Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.
Clinical trials list
click for details